相关实验视频

Updated: Jun 17, 2025

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine

Published on: November 4, 2018

精密药物和基于核酸的治疗药物用于治疗脂肪性肝病

Andrea Caddeo¹, Stefano Romeo^2,3,4,5

¹Department of Biomedical Sciences, Unit of Oncology and Molecular Pathology, University of Cagliari, Cagliari, Italy.

Clinical and molecular hepatology

|August 6, 2024

概括

包括siRNA和ASO在内的新型寡核酸疗法在治疗与代谢功能障碍相关的脂肪性肝病 (MASLD) 中表现有前途. 这些治疗针对特定的基因,提供个性化的方法超越当前的选择,如Resmetirom.

科学领域:

肝病学肝病学是一种肝病学.
分子医学是分子医学.
遗传学是一个遗传学.

背景情况:

与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的全球健康问题,导致严重的肝脏相关发病率和死亡率.
MASLD涵盖了从简单的肥胖症到进展性代谢功能障碍相关的肥胖肝炎 (MASH) 的范围,可能导致肝硬化和肝细胞癌 (HCC).
遗传,代谢和环境因素导致MASLD的复杂性和异质性.

研究的目的:

审查对MASLD的基于寡核酸的治疗方法的最新进展.
突出小干扰RNA (siRNA) 和反感性寡核酸 (ASO) 剂的发展,以MASH的遗传决定因素为目标.
讨论这些新型疗法的潜力,以解决当前MASLD治疗的局限性.

主要方法:

关于Oligonucleotide合成和MASLD的开发的当前科学文献的审查.
对基因标的分析,如涉及MASH进展的PNPLA3和HSD17B13.
在临床前和临床研究中评估siRNA和ASO的治疗潜力.

主要成果:

基于Oligonucleotide的疗法提供了一种有针对性的方法,以减少MASH.涉及的关键基因的表达.
siRNA和ASO技术已经进步,使得对MASLD的新型药物的开发成为可能.
这些疗法为现有治疗提供了潜在的替代方案或补充,解决了个性化医学的需求.

结论:

基于橄核酸的疗法是MASLD治疗的前沿,因为它针对潜在的遗传因素.
进一步的研究和开发对于优化这些药物的有效性和安全性至关重要,以便在临床上广泛使用.
针对遗传决定因素的个性化治疗策略对于管理多样化的MASLD患者群体至关重要.

关键词:

在ASO的基础上,ASO是ASO.马夫尔德 (MAFLD) 是一个马什 (MASH) 是一个非常重要的产品.这是NAFLD.siRNA 是一个RNA.

更多相关视频

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery

Published on: May 19, 2018

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes

Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins and mRNA into Freshly Isolated Primary Mouse Hepatocytes

Published on: June 2, 2022

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Ultrasound II: Endoscopic Ultrasound and FibroScan

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...